Fresenius Medical Care Ag & Co. Kgaa (FMS)

$21.32

-0.22

(-1.02%)▲

Market is closed - opens 7 PM, 03 Oct 2023

Insights on Fresenius Medical Care Ag & Co. Kgaa

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 4.70B → 4.82B (in $), with an average increase of 2.5% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 86.0M → 140.0M (in $), with an average increase of 38.6% per quarter

Performance

  • $21.17
    $21.38
    $21.32
    downward going graph

    0.7%

    Downside

    Day's Volatility :0.98%

    Upside

    0.28%

    downward going graph
  • $12.45
    $27.72
    $21.32
    downward going graph

    41.6%

    Downside

    52 Weeks Volatility :55.09%

    Upside

    23.09%

    downward going graph

Returns

PeriodFresenius Medical Care Ag & Co. KgaaSector (Health Care)Index (Russel 2000)
3 Months
-9.31%
-2.2%
0.0%
6 Months
0.0%
-1.7%
-1.8%
1 Year
51.48%
4.2%
3.5%
3 Years
-49.41%
23.6%
14.9%

Highlights

Market Capitalization
12.7B
Book Value
$23.05
Dividend Share
1.12
Dividend Yield
3.01%
Earnings Per Share (EPS)
1.07
PE Ratio
20.13
PEG Ratio
1.06
Wall Street Target Price
22.12
Profit Margin
3.04%
Operating Margin TTM
7.52%
Return On Assets TTM
2.6%
Return On Equity TTM
5.3%
Revenue TTM
19.6B
Revenue Per Share TTM
33.44
Quarterly Revenue Growth YOY
1.4000000000000001%
Gross Profit TTM
5.3B
EBITDA
2.4B
Diluted Eps TTM
1.07
Quarterly Earnings Growth YOY
-0.04
EPS Estimate Current Year
1.98
EPS Estimate Next Year
2.39
EPS Estimate Current Quarter
0.33
EPS Estimate Next Quarter
0.34

Analyst Recommendation

Hold
    7%Buy
    57%Hold
    34%Sell
Based on 26 Wall street analysts offering stock ratings for Fresenius Medical Care Ag & Co. Kgaa(by analysts ranked 0 to 5 stars)
Based on 26 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
2
2
1
Hold
15
15
15
Sell
9
9
10

Analyst Forecast

What analysts predicted

Upside of 2.06%

Current $21.32
Target $21.76

Company Financials

FY17Y/Y Change
Revenue
17.8B
↑ 4.42%
Net Income
1.3B
↑ 8.26%
Net Profit Margin
7.2%
↑ 0.26%
FY18Y/Y Change
Revenue
18.9B
↓ 6.95%
Net Income
2.3B
↑ 54.86%
Net Profit Margin
11.98%
↑ 4.78%
FY19Y/Y Change
Revenue
19.6B
↑ 5.62%
Net Income
1.3B
↓ 39.47%
Net Profit Margin
6.86%
↓ 5.12%
FY20Y/Y Change
Revenue
22.0B
↑ 2.19%
Net Income
1.4B
↓ 2.94%
Net Profit Margin
6.52%
↓ 0.34%
FY21Y/Y Change
Revenue
20.0B
↓ 1.35%
Net Income
1.1B
↓ 16.75%
Net Profit Margin
5.5%
↓ 1.02%
FY22Y/Y Change
Revenue
20.8B
↑ 10.1%
Net Income
720.9M
↓ 30.57%
Net Profit Margin
3.47%
↓ 2.03%
Q1 FY22Q/Q Change
Revenue
5.1B
↓ 2.12%
Net Income
175.6M
↓ 31.21%
Net Profit Margin
3.46%
↓ 1.46%
Q2 FY22Q/Q Change
Revenue
5.0B
↑ 4.58%
Net Income
153.7M
↓ 6.5%
Net Profit Margin
3.09%
↓ 0.37%
Q3 FY22Q/Q Change
Revenue
5.0B
↑ 7.14%
Net Income
226.2M
↑ 56.38%
Net Profit Margin
4.52%
↑ 1.43%
Q4 FY22Q/Q Change
Revenue
5.4B
↓ 1.95%
Net Income
148.9M
↓ 39.59%
Net Profit Margin
2.78%
↓ 1.74%
Q1 FY23Q/Q Change
Revenue
4.7B
↓ 5.86%
Net Income
86.0M
↓ 38.13%
Net Profit Margin
1.83%
↓ 0.95%
Q2 FY23Q/Q Change
Revenue
4.8B
↑ 2.57%
Net Income
140.0M
↑ 62.79%
Net Profit Margin
2.9%
↑ 1.07%
FY17Y/Y Change
Total Assets
24.0B
↓ 6.19%
Total Liabilities
13.2B
↓ 10.32%
FY18Y/Y Change
Total Assets
30.0B
↑ 9.23%
Total Liabilities
15.3B
↑ 1.09%
FY19Y/Y Change
Total Assets
36.9B
↑ 25.5%
Total Liabilities
22.1B
↑ 47.73%
FY20Y/Y Change
Total Assets
39.0B
↓ 3.78%
Total Liabilities
23.8B
↓ 1.77%
FY21Y/Y Change
Total Assets
38.9B
↑ 8.45%
Total Liabilities
23.1B
↑ 5.32%
FY22Y/Y Change
Total Assets
38.3B
↑ 4.04%
Total Liabilities
21.8B
↓ 0.4%
Q1 FY22Q/Q Change
Total Assets
38.8B
↑ 1.04%
Total Liabilities
22.5B
↓ 0.99%
Q2 FY22Q/Q Change
Total Assets
37.7B
↑ 3.88%
Total Liabilities
21.5B
↑ 2.15%
Q3 FY22Q/Q Change
Total Assets
37.8B
↑ 6.48%
Total Liabilities
21.3B
↑ 5.1%
Q4 FY22Q/Q Change
Total Assets
38.3B
↓ 6.91%
Total Liabilities
21.8B
↓ 6.3%
Q1 FY23Q/Q Change
Total Assets
38.7B
↓ 0.71%
Total Liabilities
22.1B
↓ 0.15%
Q2 FY23Q/Q Change
Total Assets
35.0B
↓ 1.52%
Total Liabilities
21.4B
↑ 5.71%
FY17Y/Y Change
Operating Cash Flow
2.2B
↑ 7.72%
Investing Cash Flow
-991.5M
↓ 20.43%
Financing Cash Flow
-798.6M
↑ 43.63%
FY18Y/Y Change
Operating Cash Flow
2.4B
↓ 5.93%
Investing Cash Flow
-280.3M
↓ 75.29%
Financing Cash Flow
-779.9M
↓ 14.64%
FY19Y/Y Change
Operating Cash Flow
2.9B
↑ 24.49%
Investing Cash Flow
-3.7B
↑ 1241.01%
Financing Cash Flow
-522.7M
↓ 31.55%
FY20Y/Y Change
Operating Cash Flow
5.2B
↑ 64.91%
Investing Cash Flow
-1.6B
↓ 59.37%
Financing Cash Flow
-3.3B
↑ 470.9%
FY21Y/Y Change
Operating Cash Flow
2.8B
↓ 41.19%
Investing Cash Flow
-1.4B
↓ 10.39%
Financing Cash Flow
-1.2B
↓ 61.55%
Q1 FY22Q/Q Change
Operating Cash Flow
177.1M
↓ 76.28%
Investing Cash Flow
-235.9M
↓ 50.02%
Financing Cash Flow
-297.6M
↓ 25.42%
Q2 FY22Q/Q Change
Operating Cash Flow
785.0M
↑ 373.49%
Investing Cash Flow
-206.5M
↓ 6.46%
Financing Cash Flow
-760.8M
↑ 173.13%
Q3 FY22Q/Q Change
Operating Cash Flow
646.4M
↓ 12.48%
Investing Cash Flow
-99.1M
↓ 49.01%
Financing Cash Flow
-494.0M
↓ 31.0%
Q2 FY23Q/Q Change
Operating Cash Flow
1.1B
↑ 705.11%
Investing Cash Flow
-296.6M
-
Financing Cash Flow
-700.5M
↓ 34883.76%

Technicals Summary

Sell

Neutral

Buy

Fresenius Medical Care Ag & Co. Kgaa is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Fresenius Medical Care Ag & Co. Kgaa
Fresenius Medical Care Ag & Co. Kgaa
-5.03%
0.0%
51.48%
-49.41%
-58.85%
Hca Holdings, Inc.
Hca Holdings, Inc.
-10.31%
-6.88%
27.28%
93.61%
78.34%
Universal Health Services Inc.
Universal Health Services Inc.
-2.04%
-1.13%
35.66%
12.72%
0.61%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
-1.6%
16.42%
9.4%
12.15%
29.94%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Fresenius Medical Care Ag & Co. Kgaa
Fresenius Medical Care Ag & Co. Kgaa
20.43
20.43
1.06
1.98
0.05
0.03
0.03
23.05
Hca Holdings, Inc.
Hca Holdings, Inc.
12.38
12.38
1.37
18.44
0.21
0.11
0.01
-8.44
Universal Health Services Inc.
Universal Health Services Inc.
13.17
13.17
1.87
10.19
0.11
0.05
0.01
87.72
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
18.98
18.98
0.86
7.21
0.29
0.05
0.0
11.15
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Fresenius Medical Care Ag & Co. Kgaa
Fresenius Medical Care Ag & Co. Kgaa
Hold
$12.8B
-58.85%
20.43
3.04%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$68.2B
78.34%
12.38
9.32%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$8.8B
0.61%
13.17
5.02%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$8.6B
29.94%
18.98
3.98%

Institutional Holdings

  • Pzena Investment Management, LLC

    2.84%

  • Fiduciary Management, Inc. of Milwaukee

    1.06%

  • Dodge & Cox

    0.72%

  • Amvescap Plc.

    0.17%

  • Morgan Stanley - Brokerage Accounts

    0.17%

  • Goldman Sachs Group Inc

    0.13%

Corporate Announcements

  • Fresenius Medical Care Ag & Co. Kgaa Dividends September,2022

    In the quarter ending September,2022. Fresenius Medical Care Ag & Co. Kgaa has declared dividend of $0.71

    Read More

Company Information

Fresenius Medical Care AG & Co. KGaA is an American German healthcare company which provides kidney dialysis services.

Organization
Fresenius Medical Care Ag & Co. Kgaa
Employees
124295
CEO
Ms. Helen Giza
Industry
Health Services

Discover More

FAQs